Comparison between type-2 and type-1 myocardial infarction: Clinical features, treatment strategies and outcomes

Journal of Geriatric Cardiology

Volumn 13, Issue 1, 2016, Pages 15-22

  López Cuenca, Angel ^a   Gómez Molina, Miriam ^b   Flores Blanco, Pedro J ^b   Sánchez Martínez, Marianela ^b   García Narbon, Andrea ^b   De Las Heras Gómez, Ignacio ^b   Sánchez Galian, María J ^b   Guerrero Pérez, Esther ^b   Valdés, Mariano ^b,c   Manzano Fernández, Sergio ^b,c  

^a Hospital de la Vega Lorenzo Guirao   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

Coronary vessels; Follow up studies; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; INVASIVE PROCEDURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PROGNOSIS; RECURRENT DISEASE;

EID: 84958699925     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.11909/j.issn.1671-5411.2016.01.014     Document Type: Article

References (18)

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-1598.
2. Saaby L, Poulsen TS, Diederichsen ACP, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 2014; 127: 295-302.
3. Sandoval Y, Smith SW, Apple FS. Type 2 myocardial infarction: the next frontier. Am J Med 2014; 127: e19.
4. Bonaca MP, Wiviott SD, Braunwald E, et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITONTIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Pra- sugrel-Thrombolysis in Myocardial Infarction 38). Circulation 2012; 125: 577-583.
5. El-Haddad H, Robinson E, Swett K, et al. Prognostic implications of type 2 myocardial infarctions. World J Cardiovasc Dis 2012; 2: 237-241.
6. Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011; 40: 139-146.
7. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525-2538.
8. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke J Cereb Circ 2007; 38: 1655-1711.
9. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.
10. Baron T, Hambraeus K, Sundström J, et al. Type 2 myocardial infarction in clinical practice. Heart 2015; 101: 101-106.
11. Sandoval Y, Smith SW, Thordsen SE, Apple FS. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol 2014; 63: 2079-2087.
12. Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol 2010; 139: 228-233.
13. Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013; 126: 789-797.
14. Alpert JS, Thygesen KA, White HD, et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 2014; 127: 105-108.
15. Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction-patient characteristics, management and outcomes. PloS One 2014; 9: e84285.
16. Dziewierz A, Siudak Z, Rakowski T, et al. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities. Cardiol J 2008; 15: 451-457.
17. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998; 280: 623-629.
18. Collinson PO. Type 2 myocardial infarction. Heart 2015; 101: 89-90.